Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Am J Obstet Gynecol. 2021 Dec 16;226(5):714.e1–714.e16. doi: 10.1016/j.ajog.2021.11.1374

Table 2. The association of metabolic health status and its components with fecundability (n=834).

Metabolic health indicators n Pregnancies Cycles Crude Model 1a Model 2b
FR (95% CI) FR (95% CI) FR (95% CI)
Metabolic health status
   MetS criteria ≥3 85 14 190 0.34 (0.20, 0.58) 0.38 (0.22, 0.65) 0.36 (0.21, 0.63)
   HOMA-IR ≥2.5 123 28 290 0.47 (0.32, 0.69) 0.48 (0.32, 0.72) 0.39 (0.25, 0.62)
Metabolic components
   High waist circumference (≥80 cm) 510 200 1668 0.79 (0.65, 0.97) 0.88 (0.71, 1.11) 0.94 (0.73, 1.21)
   Raised triglyceride (≥1.7 mmol/L) 61 11 161 0.37 (0.20, 0.68) 0.42 (0.23, 0.77) 0.42 (0.23, 0.78)
   Reduced HDL-C (<1.3 mmol/L) 309 117 1003 0.81 (0.65, 1.01) 0.85 (0.68, 1.08) 0.88 (0.68, 1.12)
   Raised fasting glucose (≥5.6 mmol/L) 38 6 47 0.37 (0.16, 0.82) 0.44 (0.19, 0.98) 0.45 (0.20, 1.03)
   Raised blood pressure (≥130/85 mmHg) 36 8 77 0.49 (0.24, 0.99) 0.56 (0.28, 1.13) 0.57 (0.28, 1.17)
Presence of metabolic risk markers
   0 252 126 1106 Ref. Ref. Ref.
   1 319 153 1192 0.98 (0.77, 1.24) 1.06 (0.84, 1.35) 1.08 (0.83, 1.38)
   2 178 72 572 0.84 (0.63, 1.13) 0.94 (0.70, 1.28) 0.91 (0.64, 1.29)
   3 63 11 140 0.33 (0.18, 0.62) 0.38 (0.20, 0.70) 0.35 (0.18, 0.69)
   ≥4 22 3 50 0.29 (0.09, 0.90) 0.39 (0.12, 1.23) 0.35 (0.11, 1.15)

Data were analysed using discrete-time proportional hazards models. CI, confidence interval; FR, fecundability odds ratio; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment-insulin resistance; MetS, metabolic syndrome.

a

Model 1: adjusted for age, ethnicity, education, physical activity, smoking exposure and alcohol intake.

b

Model 2: adjusted for Model 1 + body mass index.